A Single-Center Pilot Study to Assess Macular Function

Ora, Inc.

Status: Completed

Conditions: Macular Degeneration

Study type: Observational

Funder types: Industry

Identifiers

NCT01204541

10-120-0013

Details and patient eligibility

About

This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.

Enrollment: 24 patients

Sex: All

Ages: 20 to 90 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Subjects in good health aged 20-29 or 60-90 years (normal cohorts)
• Subjects with early non-exudative age-related macular degeneration (AMD cohort)

Exclusion criteria

• Enrollment in a investigational drug or device study and have used an investigational drug or device within 7 days of enrollment into this study

Trial design

24 participants in 3 patient groups

AMD

Young normals

Older normals